Rancho Santa Fe, CA, United States of America

Bradford James Duft

This inventor holds 19 USPTO granted patents and 27 published patent applications and 3 EPO patents. Top assignees: Coda Therapeutics, Inc., Ocunexus Therapeutics, Inc., Auckland Uniservices Limited. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bradford James Duft. Retrieved from https://idiyas.com/inventor/bradford-james-duft

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 42.1

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • San Diego, CA (US) (2015 - 2019)
  • Rancho Santa Fe, CA (US) (2011 - 2022)
  • Solana Beach, CA (US) (2022)

Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Bradford James Duft – Innovator in Ocular and Cytokine Modulation

Introduction

Bradford James Duft is a prominent inventor based in Rancho Santa Fe, California, known for his significant contributions to the fields of ocular treatments and cytokine modulation. With a remarkable portfolio of 19 patents, Duft has made notable advancements that address various medical disorders through innovative scientific methods.

Latest Patents

Among Duft's latest inventions are developments in channel modulators. These inventions encompass compositions and articles of manufacture featuring connexin, pannexin, gap junction, hemichannel, and pannexin channel modulators. Their applications focus on treating ocular and other disorders, demonstrating a commitment to enhancing therapeutic options in the field. Additionally, Duft has made strides in cytokine modulation through inventions that utilize hemichannel blockers. These inventions aim to modulate cytokine levels in subjects, particularly targeting the angiogenic cytokine, VEGF. By focusing on the production, secretion, and release of these cytokines, Duft's work offers potential solutions for conditions characterized by angiogenesis and vessel leak.

Career Highlights

Throughout his career, Bradford James Duft has worked with esteemed organizations, notably Coda Therapeutics, Inc. and Ocunexus Therapeutics, Inc. His roles in these companies have allowed him to collaborate on crucial projects that push the boundaries of medical innovation.

Collaborations

Duft has had the opportunity to collaborate with other intellectual leaders in his field, including Colin Richard Green and David Laurence Becker. These collaborations have further enhanced his capabilities and expanded the impact of his inventions in the medical realm.

Conclusion

Bradford James Duft's innovative contributions have made a significant mark in the fields of ocular treatment and cytokine modulation. His extensive patent portfolio reflects his dedication to advancing medical science and improving patient outcomes through targeted therapies. As he continues to innovate, the potential impact of his work is truly inspiring.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…